Avantor, Inc. (NYSE:AVTR) Stock Position Raised by Reinhart Partners LLC.

Reinhart Partners LLC. boosted its position in shares of Avantor, Inc. (NYSE:AVTR - Free Report) by 11.7% during the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 615,723 shares of the company's stock after purchasing an additional 64,450 shares during the period. Reinhart Partners LLC. owned 0.09% of Avantor worth $9,981,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the business. Dodge & Cox boosted its holdings in Avantor by 44.9% in the fourth quarter. Dodge & Cox now owns 99,145,770 shares of the company's stock worth $2,089,001,000 after purchasing an additional 30,727,673 shares in the last quarter. Vanguard Group Inc. raised its stake in shares of Avantor by 1.9% in the fourth quarter. Vanguard Group Inc. now owns 63,969,754 shares of the company's stock valued at $1,347,843,000 after purchasing an additional 1,211,418 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC lifted its holdings in shares of Avantor by 41.4% during the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 30,528,092 shares of the company's stock worth $643,227,000 after acquiring an additional 8,936,879 shares during the period. Canada Pension Plan Investment Board grew its stake in shares of Avantor by 0.5% in the 4th quarter. Canada Pension Plan Investment Board now owns 21,037,089 shares of the company's stock valued at $443,251,000 after purchasing an additional 112,644 shares during the period. Finally, Janus Henderson Group PLC grew its position in Avantor by 2.5% in the fourth quarter. Janus Henderson Group PLC now owns 18,136,206 shares of the company's stock valued at $382,131,000 after acquiring an additional 443,501 shares during the period. 95.08% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Avantor

In other news, Director Gregory L. Summe purchased 25,000 shares of the business's stock in a transaction on Wednesday, May 7th. The stock was acquired at an average price of $12.00 per share, for a total transaction of $300,000.00. Following the acquisition, the director now directly owns 50,000 shares of the company's stock, valued at $600,000. This represents a 100.00% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Joseph R. Massaro bought 8,100 shares of the firm's stock in a transaction dated Tuesday, April 29th. The shares were acquired at an average price of $12.30 per share, for a total transaction of $99,630.00. Following the completion of the transaction, the director now directly owns 35,038 shares in the company, valued at approximately $430,967.40. This represents a 30.07% increase in their position. The disclosure for this purchase can be found here. In the last ninety days, insiders have bought 83,100 shares of company stock valued at $1,027,630. 1.20% of the stock is owned by insiders.

Avantor Trading Up 1.0%

Shares of AVTR opened at $13.08 on Friday. Avantor, Inc. has a 1-year low of $11.82 and a 1-year high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70. The company has a market capitalization of $8.91 billion, a P/E ratio of 12.57, a P/E/G ratio of 1.55 and a beta of 1.09. The firm's 50 day simple moving average is $13.77 and its 200 day simple moving average is $17.70.

Avantor (NYSE:AVTR - Get Free Report) last released its quarterly earnings data on Friday, April 25th. The company reported $0.23 earnings per share for the quarter, meeting analysts' consensus estimates of $0.23. The firm had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.61 billion. Avantor had a return on equity of 12.17% and a net margin of 10.49%. The business's quarterly revenue was down 5.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.22 earnings per share. Sell-side analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on AVTR shares. Royal Bank of Canada dropped their target price on shares of Avantor from $24.00 to $20.00 and set an "outperform" rating for the company in a research note on Monday, April 28th. Stifel Nicolaus lowered shares of Avantor from a "buy" rating to a "hold" rating and decreased their price target for the company from $26.00 to $14.00 in a report on Monday, April 28th. The Goldman Sachs Group cut Avantor from a "buy" rating to a "neutral" rating and lowered their target price for the stock from $23.00 to $14.00 in a research note on Tuesday, April 29th. Wells Fargo & Company cut their price target on Avantor from $25.00 to $22.00 and set an "overweight" rating on the stock in a report on Thursday, April 17th. Finally, Raymond James reaffirmed an "outperform" rating and issued a $24.00 target price (down previously from $26.00) on shares of Avantor in a research report on Monday, February 10th. Seven equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat.com, Avantor has a consensus rating of "Hold" and a consensus price target of $18.88.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.